Irinotecan


ATC CODE

  • L01XX19

INDICATIONS AND NEMLC RECOMMENDATIONS

INDICATIONS AND NEMLC RECOMMENDATIONS 1

INDICATION

  • Adjuvant colorectal.

NEMLC RECOMMENDATION

  • Not Approved .

REVIEW INDICATORS

  • Evidence to show benefit.

DATE RATIFIED

  • 27 November 2008



INDICATIONS AND NEMLC RECOMMENDATIONS 2

INDICATION

  • First- or second-line metastatic colorectal cancer

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 10 December 2015